Skip to main content

Case of a Girl Seeking Birth Control

  • Chapter
Adolescent Gynecology

Abstract

AB is a 17-year-old girl who has migraines with aura and presents for contraceptive management. Based on the US Medical Eligibility Criteria for Contraceptive Use, estrogen-containing contraceptives are contraindicated for AB due to an elevated risk of thrombosis given her diagnosis of migraines with aura. After determining which contraceptive methods are safe, comprehensive counseling should start with a discussion of the most effective contraceptive methods including intrauterine devices (IUDs) and subdermal contraceptive implants. AB elects to have an IUD placed which is inserted the same day given it is reasonably certain she is not pregnant and no sedation is required prior to IUD placement. The only mandatory examination needed prior to IUD placement is a bimanual examination and cervical inspection in accordance with the US Selected Practice Recommendations for Contraceptive Use. Finally, condom use at every sexual encounter is recommended to reduce the risk for sexually transmitted infections.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR. 2016;65(RR-04):1–66. 10.15585/mmwr.rr6504a1.

    Article  PubMed  Google Scholar 

  2. Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR. 2016;65(RR-03):1–104. 10.15585/mmwr.rr6503a1.

    Article  PubMed  Google Scholar 

  3. Centers for Disease Control and Prevention. Summary chart of U.S. medical eligibility criteria for contraceptive use. 2016. Available via CDC. http://www.cdc.gov/reproductivehealth/contraception/pdf/summary-chart-us-medical-eligibility-criteria_508tagged.pdf. Accessed 29 July 2016.

  4. Trenor CC, Chung RJ, Michelson AD, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347–57. https://doi.org/10.1542/peds.2010-2221.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Spector JT, Kahn SR, Jones MR, et al. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med. 2010;123(7):612–24. https://doi.org/10.1016/j.amjmed.2009.12.021.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Beksinska ME, Smit JA, Kleinschmidt I, et al. Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, non-users and discontinuers of hormonal contraception. Contraception. 2010;81(1):30–4. https://doi.org/10.1016/j.contraception.2009.07.007.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Centers for Disease Control and Prevention. Providing quality family planning services: recommendations of CDC and the U.S. Office of Population Affairs. MMWR. 2014;63(RR-04):1–54.

    Google Scholar 

  8. Secura GM, Madden T, McNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med. 2014;371(14):1316–23. https://doi.org/10.1056/NEJMoa1400506.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. American Academy of Pediatrics. Contraception for adolescents. Pediatrics. 2014;134(4):1257–81. https://doi.org/10.1542/peds.2014-2300.

    Article  Google Scholar 

  10. Peipert JF, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117(5):1105–13. https://doi.org/10.1097/AOG.0b013e31821188ad.

    Article  PubMed  PubMed Central  Google Scholar 

  11. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 518: intimate partner violence. Obstet Gynecol. 2012;119:412–7. https://doi.org/10.1097/AOG.0b013e318249ff74.

    Article  Google Scholar 

  12. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 554: reproductive and sexual coercion. Obstet Gynecol. 2013;121:411–5. https://doi.org/10.1097/01.AOG.0000426427.79586.3b.

    Article  Google Scholar 

  13. Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Stewart F, et al., editors. Contraceptive technology. 18th ed. New York: Ardent Media, Inc.; 2004.

    Google Scholar 

  14. Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998–2007. https://doi.org/10.1056/NEJMoa1110855.

    Article  CAS  PubMed  Google Scholar 

  15. Funk S, Miller MM, Mishell DR, et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005;71(5):319–26.

    Article  CAS  Google Scholar 

  16. Hova GG, Skjeldestada FE, Hilstadb T. Use of IUD and subsequent fertility – follow-up after participation in a randomized clinical trial. Contraception. 2007;75(2):88–92.

    Article  Google Scholar 

  17. Stoddard AM, Xu H, Madden T, et al. Fertility after intrauterine device removal: a pilot study. Eur J Contracept Reprod Health Care. 2015;20(3):223–30. https://doi.org/10.3109/13625187.2015.1010639.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Darney P, Patel A, Rosen K, et al. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Contraception. 2009;91(5):1646–53. https://doi.org/10.1016/j.fertnstert.2008.02.140.

    Article  Google Scholar 

  19. Beatty MN, Blumenthal PD. The levonorgestrel-releasing intrauterine system: safety, efficacy, and patient acceptability. Ther Clin Risk Manag. 2009;5:561–74.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. American College of Obstetricians and Gynecologists. Practice bulletin 121: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2011;118:184–96.

    Article  Google Scholar 

  21. Eisenberg DL, Schreiber CA, Turok DK, et al. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system. Contraception. 2015;92(1):10–6. https://doi.org/10.1016/j.contraception.2015.04.006.

    Article  CAS  PubMed  Google Scholar 

  22. Nelson A, Apter D, Hauck B, et al. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol. 2013;122:1205–13. https://doi.org/10.1097/AOG.0000000000000019.

    Article  CAS  PubMed  Google Scholar 

  23. Lopez LM, Bernholc A, Zeng Y, et al. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2015;(7):CD007373. doi:https://doi.org/10.1002/14651858.CD007373.pub3.

  24. Hubacher D, Reyes V, Lillo S, et al. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol. 2006;195(5):1272–7.

    Article  CAS  Google Scholar 

  25. Sääv I, Aronsson A, Marions L, et al. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007;22(10):2647–52.

    Article  Google Scholar 

  26. Johnson BA. Insertion and removal of intrauterine devices. Am Fam Physician. 2005;71(1):95–101.

    PubMed  Google Scholar 

  27. Friedlander E, Kaneshiro B. Therapeutic options for unscheduled bleeding associated with long-acting reversible contraception. Obstet Gynecol Clin North Am. 2015;42(4):593–603. https://doi.org/10.1016/j.ogc.2015.07.004.

    Article  PubMed  Google Scholar 

  28. Madden T, Proehl S, Allsworth JE, et al. Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial. Am J Obstet Gynecol. 2012;206(129):e1–8. https://doi.org/10.1016/j.ajog.2011.09.021.

    Article  CAS  Google Scholar 

  29. Krajewski CM, Geetha D, Gomez-Lobo V. Contraceptive options for women with a history of solid-organ transplantation. Transplantation. 2013;95(10):1183–6. https://doi.org/10.1097/TP.0b013e31827c64de.

    Article  CAS  PubMed  Google Scholar 

  30. Sucato GS, Murray PJ. Developmental and reproductive health issues in adolescent solid organ transplant recipients. Semin Pediatr Surg. 2006;15(3):170–8.

    Article  Google Scholar 

  31. Maddox DD, Rahman Z. Etonogestrel (Implanon), another treatment option for contraception. Drug Forecast. 2008;33(6):337–47.

    Google Scholar 

Recommended Reading

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sofya Maslyanskaya M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Northridge, J.L., Maslyanskaya, S. (2018). Case of a Girl Seeking Birth Control. In: Talib, H.J. (eds) Adolescent Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-66978-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66978-6_18

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66977-9

  • Online ISBN: 978-3-319-66978-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics